INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 228 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,797,272 | +24.6% | 150,387 | +4.1% | 1.15% | +22.1% |
| Q2 2023 | $3,048,190 | +24.3% | 144,464 | +0.5% | 0.94% | -6.8% |
| Q1 2023 | $2,451,688 | -1.4% | 143,794 | +15.5% | 1.01% | +42.3% |
| Q4 2022 | $2,486,811 | -48.5% | 124,465 | -44.4% | 0.71% | -56.4% |
| Q3 2022 | $4,825,000 | +15.2% | 224,016 | +5.4% | 1.63% | +26.5% |
| Q2 2022 | $4,190,000 | +74.7% | 212,482 | +108.2% | 1.29% | +29.9% |
| Q1 2022 | $2,399,000 | -12.5% | 102,067 | +1.4% | 0.99% | -10.6% |
| Q4 2021 | $2,741,000 | -43.0% | 100,621 | -42.4% | 1.11% | -59.1% |
| Q3 2021 | $4,808,000 | -4.8% | 174,588 | -1.6% | 2.72% | +20.7% |
| Q2 2021 | $5,050,000 | -22.3% | 177,433 | -7.0% | 2.25% | -36.5% |
| Q1 2021 | $6,499,000 | +11.6% | 190,810 | +9.0% | 3.54% | +4.7% |
| Q4 2020 | $5,826,000 | – | 175,000 | – | 3.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |